Skip to main content

Advertisement

SpringerLink
Log in

Effects of bone anabolic agents on bone ultrastructure

  • Bone Quality Seminars: Ultrastructure
  • Published:
Osteoporosis International Aims and scope Submit manuscript

An Erratum to this article was published on 29 May 2009

An Erratum to this article was published on 29 May 2009

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Chen P, Miller PD, Recker R, Resch H, Rana A, Pavo I, Sipos AA (2007) Increases in BMD correlate with improvements in bone microarchitecture with teriparatide treatment in postmenopausal women with osteoporosis. J Bone Minere Res 22:1173–1180

    Article  CAS  Google Scholar 

  2. Paschalis EP, Glass EV, Donley DW, Eriksen EF (2005) Bone mineral and collagen quality in iliac crest biopsies of patients given teriparatide: new results from the fracture prevention trial. J Clin Endocrinol Metab 90:4644–4649

    Article  PubMed  CAS  Google Scholar 

  3. Misof BM, Roschger P, Cosman F, Kurland ES, Tesch W, Messmer P, Dempster DW et al (2003) Effects of intermittent parathyroid hormone administration on bone mineralization density in iliac crest biopsies from patients with osteoporosis: a paired study before and after treatment. J Clin Endocrinol Metab 88:1150–1156

    Article  PubMed  CAS  Google Scholar 

  4. Garnero P, Bauer DC, Mareau E, Bilezikian JP, Greenspan SL, Rosen C, Black D. Effects of parathyroid hormone and alendronate on type 1 collagen isomerization in postmenopausal women with osteoporosis: the PaTH study. J Bone Mineral Res 2008 [Epubahead of print]

  5. Boivin G, Deloffre P, Perrat B, Panczer B, Boudeulle M, Mauras Y et al (1996) Strontium distribution and interactions with bone mineral in monkey iliac bone after strontium salt (S 12911) administration. J Bone Miner Res 11:1302–1311

    Article  PubMed  CAS  Google Scholar 

  6. Farlay D, Boivin G, Panczer G, Lalande A, Meunier PJ (2005) Long-term strontium ranelate administration in monkeys preserves characteristics of bone mineral crystals and degree of mineralization of bone. J Bone Miner Res 20:1569–1578

    Article  PubMed  CAS  Google Scholar 

  7. Amman P, Badoud I, Barraud S, Dayer R, Rizzoli R (2007) Strontium ranelate treatment improves trabecular and cortical intrinsic bone tissue quality, a determinant of bone strength. J Bone Miner Res 22:1419–1425

    Article  Google Scholar 

  8. Boivin G (2007) The hydroxyapatite crystal: a closer look. Medicographia 29:126–132

    Google Scholar 

Download references

Conflicts of interest

None.

Author information

Authors and Affiliations

  1. Department of Rheumatology and EA 4032, CHU Lille, 59045, Lille, France

    B. Cortet

Authors
  1. B. Cortet
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to B. Cortet.

Additional information

An erratum to this article can be found at http://dx.doi.org/10.1007/s00198-009-0964-4

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cortet, B. Effects of bone anabolic agents on bone ultrastructure. Osteoporos Int 20, 1097–1100 (2009). https://doi.org/10.1007/s00198-009-0862-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-009-0862-9

Keywords

Search

Navigation